Hereditary angioedema: A survey of UK emergency departments and recommendations for management

European Journal of Emergency Medicine

Volumn 19, Issue 4, 2012, Pages 271-274

  Jaiganesh, Thiagarajan ^a   Hughan, Chris ^b   Webster, Anthony ^b   Bethune, Claire ^c  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b Primary Immunodeficiency Association   (United Kingdom)

^c PLYMOUTH HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

C 1 esterase inhibitor; ecallantide; hereditary angioedema; icatibant

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; ECALLANTIDE; ICATIBANT;

ANGIONEUROTIC EDEMA; ARTICLE; EMERGENCY WARD; HEALTH SERVICE; HEALTH SURVEY; HUMAN; IMMUNOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM;

ALGORITHMS; ANGIOEDEMAS, HEREDITARY; COMPLEMENT C1S; COMPLEMENT C4; EMERGENCY SERVICE, HOSPITAL; GREAT BRITAIN; HEALTH CARE SURVEYS; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84863582036     PISSN: 09699546     EISSN: 14735695     Source Type: Journal    
DOI: 10.1097/MEJ.0b013e32834c9e1f     Document Type: Article

References (12)

1. Agostoni A, Aygören-PÜrsün E, Binkley KE, Blanch A, Bork K, Bouillet L, et al. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004; 114:S51-s131. (Pubitemid 39200689)
2. Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: Absence of serum inhibitor of C 1-Esterase. Am J Med 1963; 35:37-44.
3. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: New findings concerning symptoms, affected organs, and course. Am J Med 2006; 119:267-274. (Pubitemid 43255068)
4. Gompels MM, Lock RJ, Abinun M, Bethune CA, Davis G. C1 inhibitor deficiency: Consensus document. Clin Exp Immunol 2005; 139: 379-394. (Pubitemid 40333248)
5. Bernstein IL. Hereditary angioedema: A current state-Of-The-Art review, II: Historical perspective of non-Histamine-Induced angioedema. Ann Allergy Asthma Immunol 2008; 100:S2-s6.
6. Frank MM. Hereditary angioedema. J Allergy Clin Immunol 2008; 121:S398-s401.
7. Primary Immunodeficiency Association, www.pia.org.uk.
8. Pappalardo E, Cicardi M, Duponchel C, Carugati A, Choquet S, Agostoni A, Tosi M. Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema. J Allergy Clin Immunol 2000; 106:1147-1154. (Pubitemid 32006270)
9. Kunschak M, Engl W, Maritsch F, Rosen FS, Eder G, Zerlauth G, et al. Randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion 1998; 38:540-549. (Pubitemid 28317229)
10. Zuraw BL. HAE therapies: Past present and future. Allergy Asthma Clin Immunol 2010; 6:23.
11. Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, et al. International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010; 6:24.
12. Zilberberg M, Jacobsen T, Tillotson G. The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007. Allergy Asthma Proc 2010; 31:511-519.